A groundbreaking ceremony for a new mRNA vaccine factory owned by the biotechnology business Moderna was attended by Prime Minister Justin Trudeau today in Laval, Quebec, a suburb of Montreal.
At the earliest, the facility is anticipated to be finished in 2024 and produce 100 million doses of mRNA vaccines annually.
It will manufacture vaccines against COVID-19 and other respiratory viruses, including influenza and respiratory syncytial virus, or RSV.
Today, Trudeau was accompanied by a number of federal and provincial leaders, including Laval Mayor Stéphane Boyer and federal Innovation Minister François-Philippe Champagne.
The prime minister told reporters that Moderna’s new factory represents an investment in the health-care security of Canadians and also in a research ecosystem that will deliver good jobs for years to come.
Champagne claimed that Canada had agreed to buy a specific quantity of vaccines from the plant, but he gave no further information.
Federal officials dedicate Moderna’s mRNA vaccination plant in the Montreal region.
About Author
